These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 834763)

  • 21. [Intermittent chemotherapy of patients with newly detected pulmonary tuberculosis].
    Rabukhin AE; Gol'dshteĭn VD; Khodakevich LIa
    Probl Tuberk; 1974; (7):14-8. PubMed ID: 4409887
    [No Abstract]   [Full Text] [Related]  

  • 22. [Rifampicin in the treatment of pulmonary tuberculosis].
    Daddi G; Lucchesi M; Rossi P; Sbampato M
    Ann Ist Carlo Forlanini; 1969; 29(1):3-16. PubMed ID: 5405840
    [No Abstract]   [Full Text] [Related]  

  • 23. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
    Khodashova ML; Iuditskiĭ MV; Semenova OV
    Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The course of pulmonary tuberculosis in the initial phase of various intensive therapy combinations].
    Kindler U; Derichs R; Merholz S
    Med Welt; 1976 Feb; 27(8):387-8. PubMed ID: 1256307
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of intractable pulmonary tuberculosis: place of capreomycin in therapeutic programs with rifampicin and ethambutol].
    Oury M; Tuchais E; Norval C; Carbonnelle B; Leroux MF; Corre C; Parvery F
    Rev Tuberc Pneumol (Paris); 1970 Jun; 34(4):519-30. PubMed ID: 5510321
    [No Abstract]   [Full Text] [Related]  

  • 26. [Remote (2-3 years) results in patients with pulmonary tuberculosis treated in operational conditions in combination with sinerdol-EH].
    Păunescu E; Mihăilescu P; Fonea M; Ciocan A; Serban G; Eliescu A; Serban S; Grigorescu C; Tiţei I; Popescu M
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1987; 36(2):137-44. PubMed ID: 2825331
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of pleural and pulmonary tuberculosis by drug combinations including rifampicin. Early results].
    Cornudella R; Garcia-Besada JA; Castellano A
    Rev Clin Esp; 1972 Jul; 126(1):59-64. PubMed ID: 5080189
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 2. Results of rifampicin treatment for advanced pulmonary tuberculosis patients resistant to conventional antituberculous drugs].
    Kekkaku; 1971 Nov; 46(11):423-8. PubMed ID: 4335256
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical course and effectiveness of treatment of destructive pulmonary tuberculosis in adolescents].
    Firsova VA; Nadyrshina RSh; Melikova VM
    Probl Tuberk; 1986; (5):14-7. PubMed ID: 3737587
    [No Abstract]   [Full Text] [Related]  

  • 30. [Short-term treatment of tuberculosis with and without pyrazinamide in the second phase (TA-80)].
    Farga V; Valenzuela P; Yañez A; Valenzuela MT; Scheel G; Mendoza F; Torres E; Icekson I; Grinspun M; Fernández M
    Rev Med Chil; 1983 Jul; 111(7):750-4. PubMed ID: 6680460
    [No Abstract]   [Full Text] [Related]  

  • 31. [Preliminary clinical observations on the use of Rifampicin in chronic cavitary pulmonary tuberculosis previously treated with and resistant to other drugs].
    Mauro G
    Arch Tisiol Mal Appar Respir; 1968 Jun; 23(6):461-6. PubMed ID: 5309059
    [No Abstract]   [Full Text] [Related]  

  • 32. [Short-term treatment of pulmonary tuberculosis].
    Karuga WK
    Bull Int Union Tuberc; 1974; 49(1):388-97. PubMed ID: 4143178
    [No Abstract]   [Full Text] [Related]  

  • 33. [Short-course chemotherapy for tuberculosis in Chile. Operational considerations].
    Valenzuela P; Valenzuela MT
    Rev Med Chil; 1984 Mar; 112(3):287-9. PubMed ID: 6473970
    [No Abstract]   [Full Text] [Related]  

  • 34. [An experimental study of the chemotherapeutic efficacy of flurenizid, a new antitubercular pharmaceutical].
    Khomenko AG; Golyshevskaia VI; Maslova LI; Kalmykova GN; Uvarova OA
    Probl Tuberk; 1990; (6):3-7. PubMed ID: 2217100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-course treatment regimens for patients with tuberculosis.
    Dutt AK; Stead WW
    Arch Intern Med; 1980 Jun; 140(6):827-9. PubMed ID: 6770770
    [No Abstract]   [Full Text] [Related]  

  • 36. [The therapeutic action of Rifampicin, a derivative of 3-(4-methyl-1-piperazinyl-iminomethyl)-rifamycin SV, in pulmonary tuberculosis].
    Lucchesi M; Pallotta G; Rossi P; Sbampato M
    Ann Ist Carlo Forlanini; 1967; 27(3):199-227. PubMed ID: 5602885
    [No Abstract]   [Full Text] [Related]  

  • 37. Widespread distribution of a single drug rifampicin formulation of inferior bioavailability in South Africa.
    Bhaduri J
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1128-9; author reply 1129. PubMed ID: 12546124
    [No Abstract]   [Full Text] [Related]  

  • 38. [Therapy of pulmonary tuberculosis].
    Schlapper K
    Munch Med Wochenschr; 1972 Oct; 114(42):1821-4. PubMed ID: 4563806
    [No Abstract]   [Full Text] [Related]  

  • 39. [Short-course treatment of tuberculosis on a 7-month schedule with an initial intensive phase of 1 month (TA-81)].
    Farga V; Valenzuela P; Yañez A; Valenzuela MT; Scheel G; Mendoza F; Torres E; Icekson I; Grinspun M; Fernández M
    Rev Med Chil; 1984 Mar; 112(3):290-5. PubMed ID: 6473971
    [No Abstract]   [Full Text] [Related]  

  • 40. Pyrazinamide serum levels in childhood tuberculosis.
    Thee S; Detjen A; Wahn U; Magdorf K
    Int J Tuberc Lung Dis; 2008 Sep; 12(9):1099-101. PubMed ID: 18713511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.